Skip to main content
Pamela Kunz, MD, Oncology, North Haven, CT

PamelaLynKunzMD

Oncology North Haven, CT

Gastrointestinal Cancer

Associate Professor, Medicine - Oncology, Yale Cancer Center

Dr. Kunz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kunz's full profile

Already have an account?

  • Office

    Smilow Cancer Hospital - Yale North Haven
    6 Devine Street
    North Haven, CT 06473
    Phone+1 203-200-4422
    Fax+1 203-200-6950

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2008
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2004 - 2005
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2001 - 2004
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • CT State Medical License
    CT State Medical License 2020 - 2026
  • NY State Medical License
    NY State Medical License 2024 - 2026
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Resear... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Common Cancer Type Could Be Detected with New Blood Test
    Common Cancer Type Could Be Detected with New Blood TestFebruary 4th, 2025
  • Can Aspirin Improve Colorectal Cancer Outcomes?
    Can Aspirin Improve Colorectal Cancer Outcomes?February 3rd, 2025
  • Daily Aspirin Reduces Colon Cancer Risk, Study Shows
    Daily Aspirin Reduces Colon Cancer Risk, Study ShowsJanuary 29th, 2025
  • Join now to see all

Professional Memberships